Aerococcus: Difference between revisions

From IDWiki
Aerococcus
mNo edit summary
No edit summary
 
(One intermediate revision by the same user not shown)
Line 15: Line 15:
== Management ==
== Management ==


* [[Penicillin]] ± [[aminoglycoside]] (for synergy, based on in vitro studies)
* [[Penicillin]] or [[ampicillin]]
* ± [[aminoglycoside]] (for synergy, based on in vitro studies)
* Can be susceptible to [[ceftriaxone]], though MICs are higher than for [[penicillin]]


== Further Reading ==
{{DISPLAYTITLE:''Aerococcus''}}

* ''Aerococcus'': an increasingly acknowledged human pathogen. ''Clin Microbiol Infect''. 2016 Jan;22(1):22-27. doi: [https://doi.org/10.1016/j.cmi.2015.09.026 10.1016/j.cmi.2015.09.026]. PMID: [https://pubmed.ncbi.nlm.nih.gov/26454061/ 26454061].{{DISPLAYTITLE:''Aerococcus''}}
[[Category:Gram-positive cocci]]
[[Category:Gram-positive cocci]]

Latest revision as of 18:10, 21 June 2024

Microbiology

  • Gram-positive coccus
  • Notable species
  • Presumed resistance in vivo to TMP-SMX, even though it may appear susceptible in vitro
    • It can acquire folate from the host's urine, counteracting the antibiotic

Clinical Manifestations

Management

Further Reading